The Valley Desk

NCT02983799 · Interventional trial

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Overall registry status Completed

Phase 2

Conditions Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov